Polfa Tarchomin S.A.

We are proud of our 70 years of experience in supporting patients’ health with high quality APIs and becoming a leading European CDMO partner. API manufacturing is carried out in cGMP-compliant and FDA-approved multipurpose plant. Area dedicated to: POLPHARMA API PRODUCTION: 6,2 ha. Buildings dedicated to: Polpharma API production: 19.246 m2. API manufacturing is carried out in a cGMP-compliant and FDA-approved multipurpose plant. For over 80 years, trusted by patients, healthcare professionals, and business partners alike. A leading regional (CEE and CIS) manufacturer of pharmaceuticals and a leader in the Polish & Kazakhstan pharmaceutical market. Thanks to best-in-class industry talents and state-of-the-art technologies, we are able to design and deliver crucial products and solutions to address the biggest health challenges (an aging population, chronic diseases) and healthcare system problems (increasing healthcare costs, resource shortages).

As we are constantly thinking about the future, we care for the environment by optimising energy consumption, segregating waste and starting pro-environmental projects. PHYTOPHARMAKON 2000 International Scientific Symposium is organised in Poznań to celebrate the 50th anniversary of the company. Our products are manufactured using the highest quality active ingredients with proven effectiveness and confirmed safety of use. We provide our customers with plant products intended for prevention and treatment. Consumers and pharmacists have trusted our products for many years. Many of the products rank top in their therapeutic categories. Therefore, we can safely say that it is one of the most advanced production facilities in the country. Pharmaceutical production starts — “Wytwórnia nr 11” (Factory No.

Our comprehensive portfolio currently includes about 185 pharmaceutical products covering a broad range of therapeutic areas. We offer a wide range of dosage forms including immediate and modified release tablets and capsules, soluble and oro-dispersible tablets, soft gel capsules, nasal suspensions, ointments, gels, oral liquids and injectables. Our vast experience in launching new products together with our proven regulatory skills, enable us to achieve fast and successful results. We offer range of specialist oncology products and product formulations, mainly in the form of tablets, capsules and injections.

The company has set up modern manufacturing facilities conforming to international standards. This will provide exclusive production facilities and increased capacity to manufacture oral liquids, oral solids and Nutraceutical products, apart from giving us the additional capacity to undertake contract manufacturing. These units are built to regulatory specifications and will be able to produce and supply products to the global market. Having a strong quality conscious associate WHO-GMP & GMP manufacturing facilities for bulk and finished products spread across India, we are efficiently backed up by an a team of excellent technocrats & professionals. Continuously offering unique products and services that would give customers utmost satisfaction and constantly working on smart marketing to maintain the clarity of product positioning Our core strength has been in creating, maintaining and sustaining mutually beneficial business relations with the Top Indian Players including national as well as Multinational Organizations in India. To become an International corporation in the field of Pharmaceutical healthcare industry by offering innovative quality products at affordable cost to the mankind. We operate with effective governance; maintain reputation of transparency, openness, fairness, and high standards of ethical behavior. Our company has always concentrated on developing manufacturing infrastructure needed to efficiently produce the basket of products we are traditionally well placed in - and have continually put in effort & resources to develop our site in Pondicherry into a world class manufacturing complex.

We are committed to providing prompt and comprehensive assistance to meet your pharmaceutical business needs. We are also actively developing solid forms and production capabilities for both sterile and non-sterile drops. As part of our services, we offer contract manufacturing of final dosage forms for human use. Yes, we are fully compliant with all relevant regulatory standards, including European Union Good Manufacturing Practices (GMP) and other applicable guidelines. Our manufacturing process strictly adheres to the GMP principles, ensuring top-notch standards in all aspects of production. We specialize in the manufacturing of both dry and liquid injectable and infusible preparations, as well as product packaging and serialization. As the assignee of MedicProduct a.s., MediPharm a.s. With a rich heritage of 25 years in pharmaceutical production based in Lipany, Slovak Republic, MediPharm a.s.

We provide security and fulfillment to our employees and strive for excellence in all that we do. We are accountable to our shareholders and make a profit for them over the long term by innovating and investing. We are experienced in technology transfers and scale-up process for commercial production. We manufacture quality generic medicines on a contractual basis for EU and Chinese customers with competitive pricing. We are confident in our ability to work with customers from all countries from our facilities in China. We manufacture solid oral dosage forms for customers in Europe and are adding liquid forms in 2020. We were granted our EU Good Manufacturing Practice (GMP) Certificate in 2010 following inspection by the UK Medicines and Healthcare Products Regulatory Agency (MHRA). Our dedication to manufacturing products of the highest quality can also be demonstrated by our facilities passing quality inspections by many customers including Novartis, Teva, Wockhardt, Genesis and Krka.